期刊文献+

IL-12瘤苗联合放疗对小鼠Lewis肺癌作用研究 被引量:2

The Studies onEffects of the Interleukin-12 Tumor Vaccine plus Radiotherapy of Murine Lewis Lung Cancer
下载PDF
导出
摘要 目的:建立稳定表达小鼠IL-12(Murine interleukin-12,mIL-12)的小鼠Lewis肺癌(Lewis lung carcino-ma,LLC)瘤苗LLC/mIL-12,评估瘤苗对荷鼠Lewis肺癌C57BL/6小鼠的放疗增敏作用。方法:重组质粒pcD-NA3.1(+)-mIL-12用脂质体转染LLC,G418筛选后获得LLC/mIL-12瘤苗。C57BL/6小鼠皮下接种LLC细胞2×106,成瘤后将小鼠随机分成4组(n=10),第0、7、14d瘤苗组和联合组瘤内注射瘤苗,第1、3、5d放疗和联合组给予2Gy局部照射。第21d处死小鼠,观察肿瘤体积、脾细胞中CTL和NK活性以及肿瘤细胞凋亡。结果:联合组肿瘤体积显著缩小,NK和CTL活性增强,凋亡增加,与其它组相比,P<0.05;放疗组NK和CTL活性降低。结论:LLC/mIL-12瘤苗及放疗均能产生抗瘤反应,且联合组作用更强。瘤苗放疗增敏作用机制是诱导细胞凋亡,增强NK和CTL活性。 Objective: To test LLC/mIL-12, a tumor vaccine for murine Lewis lung carcinoma (LLC), and to assess radiosensitization of the murine LLC cells after transfection with the murine IL-12 gene in Lewis lung tumor-bearing mice. Methods: The recombinant plasmid pcDNA3.1 (+) -miL-12 was transfected into the LLC cells via liposome, and then clones positive for LLC/ miL-12 were obtained by screening with G418. Hypodermic inoculation of 2×10^6 LLC cells into the C57BL/6 mice (n=10) was conducted and the mice were randomized into 4 groups after tumorigenesis. The tumor vaccine was administered to the vaccine group and the combination group on day 0, 7 and 14, and local irradiation with 2Gy was administered in the radiotherapy group and the combination group on day 1, 3 and 5. The mice were sacrificed on day 21, and the tumor size, the activity of cytotoxic T lymphocytes (CTL) and natural killer cells (NK), and the apoptotic activity of the tumor cells were observed. Results: In the combined group the size of tumors was significantly smaller, activity of the NK and CTL was enhanced, and apoptosis was increased, compared to the other groups (P〈0.05). The activity of the NK and CTL in the radiotherapy group was reduced. Conclusion: Antitumor immune response can be induced in the radiotherapy group and the LLC/mIL-12 vaccine group, but it is much stronger in the combination group. The mechanism of vaccine radiosensitization includes induction of cell apoptosis and enhancement of NK and CTL activity.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第2期100-103,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30370422)
关键词 IL-12瘤苗 放射治疗 LEWIS肺癌 nterleukin- 12 vaccine Radiotherapy Lewis lung cancer
  • 相关文献

参考文献10

  • 1Ron IG,Sarid D,Ryvo L,et al.A biochemotherapy regimen with concurrent administration of cisplatin,vinblastine,temozolomide (Temodal),interferon-alfa and interleukin-2 for metastatic melanoma:a phase Ⅱ study[J].Melanoma Res,2006,16(1):65 ~69
  • 2Taphoom MJ,Bromberg J E.Neurological effects of therapeutic irradiation[J].Continuum Lifelong Leami Neurol,2005,11 (5):93~115
  • 3尹晓玲,孙世良,李少林,彭志平,蒋明东.小鼠白介素-12真核表达质粒的构建及其表达[J].中华肿瘤防治杂志,2006,13(3):165-168. 被引量:4
  • 4Stevenson,F K.Update on cancer vaccines[J].Curr Opin Oncol,2005,17(6):573~577
  • 5Dobelbower MC,Russo SM,Raisch KP,et al.Epidermal growth factor receptor tyrosine kinase inhibitor,erlotinib,and concurrent 5-fluorouracil,cisplatin and radiotherapy for patients with esophageal cancer:a phase I study[J].Anti-Cancer DrugS,2006,17(1):95~102
  • 6Kikuchi T,Akasaki Y,Abe T,et al.Vaccination of Glioma Patients with fusions of dendritic and glioma cells and recombinant human interleukin 12[J].J Immunother,2004,27 (6):452 ~459
  • 7Ma BB,Bristow RG,Kim J,et al.Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents[J].J Clini Oncol,2003,21(14):2760~2776
  • 8Iwashita Y,Goto S,Tominaga M,et al.Dendritic cell immunotherapy with poly (D,L-2,4-diaminobutyric acid)-mediated intratumoral delivery of the interleukin-12 gene suppresses tumor growth significantly[J].Cancer ScieNCE,2005,96(5):303~307
  • 9Peron JM,Couderc B,Rochaix P,et al.Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12[J].J Gastroenterol Hepatol,2004,19:388~396
  • 10Soiffer R,Hodi FS,Haluska F,et al.Vaccination with irradiated,autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma[J].J Clin Oncol,2003,21(17):3343 ~ 3350

二级参考文献9

  • 1孙卫民 王惠琴.细胞因子研究方法学[M].北京:人民卫生出版社,1998.540-581.
  • 2Lamonta A,Adorini L.IL-12:a key cytokine in immune regulation[J].Immune Today,1996,17(5):214-217.
  • 3Mally B W,Chen S H,Schwartz M R,et al.Adenovirus-medited gene therapy for human head neck squamous cell cancer in a nude mouse model[J].Cancer Res,1995,55(4):1080-1085.
  • 4Pailard F.The search for the "best"cytokine to induce antitumor immunite[J].Human Gene Therapy,1998,9 (17):2457-2458.
  • 5Trinchieri G.Interleukin-12:a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antiggenspecific adaptive immunity[J].Annu Rev Immunol,1995,13(8):251 -276.
  • 6Yuji S,Clemens E,Andrea G,et al.Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice[J].Journal Of Experimental Therapeutics And Oncology,1998,2(6):337.
  • 7Ha S J,Lee S B,Kim C M,et al.Rapid recruitment of macrophages in interleukin-12-mediated tumor regression[J].Immunology,1998,95(1):156-163.
  • 8杨英,刘树铮,付士波.pNEgr-mIL-12真核表达载体的体外和体内生物学活性检测[J].生物化学与生物物理进展,2002,29(5):790-795. 被引量:4
  • 9隋延仿,李增山.肿瘤疫苗研究进展[J].现代肿瘤医学,2003,11(4):241-244. 被引量:5

共引文献3

同被引文献17

  • 1薛一峰,刘洁,宫玲玲,虞竞峰.哮喘患者痰中IL-15、IL-13的定量检测及其临床意义[J].实用临床医药杂志,2005,9(1):68-68. 被引量:1
  • 2刘勇,吴峰.白介素-12治疗支气管哮喘的研究进展[J].国际呼吸杂志,2007,27(11):851-854. 被引量:2
  • 3Koichi Matsumoto, Hiroyuki Ohi, Katsuo Kanmatsuse. Interleukine-15 and interleukine-12 have an additive effect on the release of vascular permeability cells in normals and in patients with nephritic syndrome[J]. Clin Nephr, 1999 ;52 ( 1 ) : 10 - 18
  • 4A1-Hajj M, Wicha M S, Benito-Hernandez Aet al. Prospective iden- tification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA, 2003 ; 100:3983-3988.
  • 5Singh S K, Hawkins C, Clarke I D et al. Identification of human brain tumour initiating ceils[ J]. Nature, 2004 ;432:396-401.
  • 6O' Brien C A, Pollett A, Gallinger S et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[ J]. Nature, 2007 ;445 : 106-110.
  • 7Ricci-Vitiani L, Lombardi D G, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells [ J ]. Nature, 2007; 445:111-115.
  • 8Todaro M, Alea M P, Di Stefano A Bet al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin- 4[J]. Cell Stem Cell, 2007;1:389-402.
  • 9Trinchieri G. Interleukin-12:a cytokine produced by antigen-presen-ting cells with immunoregulatory functions in the generation of T help- er-typel ( Thl ) cells and cytotoxic lymphocytes[ J]. Blood, 1994 ;84 : 4008-4027.
  • 10Cebon J, Jager E, Shackleton M Jet al. Two phase I studies of low dose recombinant human IL-12 with melan-A and influenza peptides in subjects with advanced malignant melanoma[ J ]. Cancer Immun, 2003 ;3:7-10.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部